The government has increased the cost of certain essential drugs for treating asthma, tuberculosis and others.

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

India's drug pricing authority has increased the prices of essential drugs for conditions like asthma and tuberculosis, ...

Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the ...

India's drug pricing authority has hiked the prices of drugs for conditions like asthma, tuberculosis, and mental health.

The price cap revision will apply to various formulations of benzyl penicillin, atropine, streptomycin, salbutamol, ...

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

The connection between respiratory infections, chronic diseases like asthma, and the gut microbiome drives research toward ...

Doctors are to be taught to avoid giving asthma patients traditional inhalers if possible because of the greenhouse gases ...

India's National Pharmaceutical Pricing Authority (NPPA) has raised the ceiling price of 11 essential drugs by 50% to ensure ...

New Delhi: India’s apex drug pricing regulator Monday allowed a 50 percent rise in the prices of 8 essential drugs used by ...